未登录

Y

Yingliang Wu

Shenyang Pharmaceutical University

H指数:35

被引数:3,588

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Tick Saliva Peptide HIDfsin2 TLR4-Dependently Inhibits the Tick-Borne Severe Fever with Thrombocytopenia Syndrome Virus in Mouse Macrophages

ANTIBIOTICS-BASEL

IF4.6

2024-05-152

OA

CD74-ROS1 L2026M mutant enhances autophagy through the MEK/ERK pathway to promote invasion, metastasis and crizotinib resistance in non-small cell lung cancer cells

IF4.2

2024-01-125

PRE

Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-06-019

PRE

Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2023-01-0119

PRE

XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-11-0116

OAAI

Dynamic synthesis and transport of fluorescent substances from moulting scorpions

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

IF3.7

2022-09-011

PRE

A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2022-07-019

OAAI

2-Methoxy-5((3,4,5-trimethosyphenyl) seleninyl) phenol causes G2/M cell cycle arrest and apoptosis in NSCLC cells through mitochondrial apoptotic pathway and MDM2 inhibition

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

IF2.8

2022-04-054

PRE

EML4-ALK G1202R mutation induces EMT and confers resistance to ceritinib in NSCLC cells via activation of STAT3/Slug signaling

CELLULAR SIGNALLING

IF3.7

2022-04-0114

PRE

Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer

IF10.1

2022-04-0112

PRE

Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ ADR cells by inhibiting BCRP function and mediating apoptosis

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2022-02-013

PRE

W436, a novel SMART derivative, exhibits anti-hepatocarcinoma activity by inducing apoptosis and G2/M cell cycle arrest in vitro and in vivo and induces protective autophagy

W436是一种新型的SMART衍生物，通过在体外和体内诱导凋亡和G2/M细胞周期阻滞表现出抗肝癌活性，并诱导保护性自噬

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

IF2.8

2021-06-212

PREAI

The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy

PD-1和PD-L1检查点信号抑制在乳腺癌免疫治疗中的研究进展

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-03-0125

PREAI

Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2021-01-3112

OAAI

The novel ALK inhibitor ZX-29 induces apoptosis through inhibiting ALK and inducing ROS-mediated endoplasmic reticulum stress in Karpas299 cells

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

IF2.8

2020-11-025

PREAI

Recent advances of molecular mechanisms of regulating PD-L1 expression in melanoma

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-11-0111

PREAI

Recent advances and challenges of immune checkpoint inhibitors in immunotherapy of non-small cell lung cancer

免疫检查点抑制剂在非小细胞肺癌免疫治疗中的研究进展与挑战

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-08-0127

PREAI

Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells

BIOCHEMICAL PHARMACOLOGY

IF5.6

2020-05-0121

OAAI

Design, synthesis and bio-evaluation of novel 2-aryl-4-(3,4,5-trimethoxy-benzoyl)-5-substituted-1,2,3-triazoles as the tubulin polymerization inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-01-0121

PREAI

A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2019-11-019

PREAI